Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

CYKLOKAPRON® Contraindications (tranexamic acid)

4 CONTRAINDICATIONS

CYKLOKAPRON Injection is contraindicated:

  • In patients with subarachnoid hemorrhage. Anecdotal experience indicates that cerebral edema and cerebral infarction may be caused by CYKLOKAPRON in such patients.
  • In patients with active intravascular clotting [see Warnings and Precautions (5.1)].
  • In patients with hypersensitivity to tranexamic acid or any of the ingredients [see Warnings and Precautions (5.4)].
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event